EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tumor‐derived mitochondrial formyl peptides suppress tumor immunity through modification of the tumor microenvironment

Kayoko Waki, Miyako Ozawa, Keisuke Ohta, Nobukazu Komatsu, Akira Yamada iD

Cancer Science · 2024

DOI: 10.1111/cas.16266 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Kayoko Waki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Immunology Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka, Japan. Hauptthemen laut MEDLINE: Tumor Microenvironment, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial N ‐formylpeptides are released from damaged or dead cells to the extracellular spaces and cause inflammatory responses. The role of mitochondrial N‐ formylpeptides in aseptic systemic inflammatory response syndromes induced by trauma or cardiac surgery has been well investigated. However, there are no reports regarding the role of mitochondrial N‐ formylpeptides in cancer. In this study, we investigated the role of tumor cell‐derived mitochondrial N‐ formylpeptides in anti‐tumor immunity using knockout murine tumor cells of mitochondrial methionyl‐tRNA formyltransferase (MTFMT), which catalyze N‐ formylation of mitochondrial DNA‐encoded proteins. There was no apparent difference among the wild‐type and MTFMT‐knockout clones of E.G7‐OVA cells with respect to morphology, mitochondrial dynamics, glycolysis and oxidative phosphorylation, oxygen consumption rate, or in vitro cell growth. In contrast, in vivo tumor growth of MTFMT‐knockout cells was slower than that of wild‐type cells. A reduced number of myeloid‐derived suppressor cells and an increase of cytotoxic T‐lymphocytes in the tumor tissues were observed in the MTFMT‐knockout tumors. These results suggested that tumor cell‐derived mitochondrial N‐ formylpeptides had a negative role in the host anti‐tumor immunity through modification of the tumor microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentMitochondriaAnimalsMiceCell Line, TumorMice, KnockoutHydroxymethyl and Formyl TransferasesMice, Inbred C57BLT-Lymphocytes, CytotoxicMyeloid-Derived Suppressor CellsNeoplasmsPeptidesOxidative PhosphorylationCell Proliferation

Stichwörter der Autor:innen

DAMPsalarminmitochondrial formyl peptidetumor immunitytumor microenvironment

Substanzen

Hydroxymethyl and Formyl TransferasesPeptides

Autor:innen und Institutionen

  • Tumor Immunology Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka, Japan.
  • Advanced Imaging Research Center, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
  • Department of Immunology, Kurume University School of Medicine, Kurume, Fukuoka, Japan.

ORCID-Profile: Akira Yamada

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Waki, K., Ozawa, M., Ohta, K., Komatsu, N., & Yamada, A. (2024). Tumor‐derived mitochondrial formyl peptides suppress tumor immunity through modification of the tumor microenvironment. Cancer Science. https://doi.org/10.1111/cas.16266

Vancouver

Waki K, Ozawa M, Ohta K, Komatsu N, Yamada A. Tumor‐derived mitochondrial formyl peptides suppress tumor immunity through modification of the tumor microenvironment. Cancer Science. 2024. doi:10.1111/cas.16266

BibTeX
@article{Waki2024,
  author = {Waki, Kayoko and Ozawa, Miyako and Ohta, Keisuke and Komatsu, Nobukazu and Yamada, Akira},
  title = {Tumor‐derived mitochondrial formyl peptides suppress tumor immunity through modification of the tumor microenvironment},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16266}
}
Kostenlos starten →